Literature DB >> 31145253

Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.

Vickey J Said1, Edith Garcia-Trujillo.   

Abstract

Hepatic encephalopathy is a complication of liver failure characterized by neuropsychiatric dysfunction ranging from disorientation to coma. There is a need for more treatment options and preventive care interventions to reduce the incidence of hepatic encephalopathy and mitigate its socioeconomic impact on families and strain on healthcare resources. Currently, there is no consensus on a single pathophysiological mechanism responsible for the development of this neurocognitive disorder. Ammonia toxicity remains a significant factor, but there is now increased recognition that hyperammonemia acts synergistically with systemic inflammation, oxidative stress, and gut microbiota imbalance in the development of hepatic encephalopathy. This article provides an overview of current and emerging therapies that target these factors in the treatment and management of this condition. Because of its complex pathogenesis, a multipronged approach to treating hepatic encephalopathy may be highly beneficial.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31145253     DOI: 10.1097/SGA.0000000000000376

Source DB:  PubMed          Journal:  Gastroenterol Nurs        ISSN: 1042-895X            Impact factor:   0.978


  2 in total

Review 1.  Hyperammonemia Post Lung Transplantation: A Review.

Authors:  Robert F Leger; Matthew S Silverman; Ellen S Hauck; Ksenia D Guvakova
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2020-10-26

2.  Application of fecal microbial transplantation in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Authors:  Jun Li; Dan Wang; Jingping Sun
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.